0R1F Stock Price, Chart, Stats & News
Bristol-Myers Squibb Company (0R1F) is a dividend-paying stock with a current dividend yield of 4.28% as of Jul 16, 2026. It pays $2.51 per share over the trailing twelve months and distributes quarterly. Its dividend has grown at a 1.15% 5-year compound annual rate.
Dividend safety
Dividend coverage is moderate for 0R1F — worth a closer look at the full safety breakdown.
0R1F chart
About
Bristol-Myers Squibb Company is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, and commercialization of pharmaceutical products. Its extensive portfolio of medicines targets a wide array of serious medical conditions, including those in the fields of hematology, oncology, cardiovascular health, immunology, fibrotic disorders, neuroscience, and COVID-19. The company's prominent therapies include Revlimid, an oral immunomodulator prescribed for multiple myeloma; Eliquis, an oral inhibitor used to lower the risk of stroke/systemic embolism in non-valvular atrial fibrillation and to treat deep vein thrombosis/pulmonary embolism; and Opdivo, a key anti-cancer agent.
Related lists
Similar securities
Based on sector and market capitalization
